Systemic Nalbuphine Versus Intravenous Regional Anesthesia

Not Applicable

Completed

• Conditions: Postoperative Pain
• Interventions: Drug: Local nalbuphine; Drug: Systemic nalbuphine

• Registration Number: NCT03150732
• Lead Sponsor: Assiut University

Brief Summary

Comparison of systemic nalbuphine versus intravenous regional anesthesia in patients undergoing hand surgery.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2017-05-08
• Study First Submitted QC: 2017-05-10
• Study First Posted: 2017-05-12
• Study Start: 2022-08-10
• Status Verified: 2024-02
• Primary Completion: 2024-02-10
• Study Completion: 2024-02-10
• Last Update Submitted: 2024-02-18
• Last Update Posted: 2024-02-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 82

Inclusion Criteria

• Patients scheduled for elective unilateral hand surgery.

Read More

Exclusion Criteria

• Patient refusal.
• Allergy to study medications
• Body mass index > 35 kg/ m2
• Patients with sickle cell or Reynaud diseases
• Patients with a history of psychiatric illness or on chronic opioids

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Local nalbuphine group	Local nalbuphine	53 patients will receive nalbuphine with local intravenous regional anesthesia (IVRA)
Systemic nalbuphine group	Systemic nalbuphine	53 patients will receive nalbuphine systemically

Primary Outcome Measures

Name	Time	Method
Duration of postoperative Analgesia	Postoperative 24 hours	minutes

Secondary Outcome Measures

Name	Time	Method
Diclofenac analgesic consumption	Postoperative 24 hours	mg
Cortisol level	Preoperative and at 4 hours after skin incision	Level of cortisone in blood (nmol/L)
Severity of postoperative Pain	Postoperative 24 hours	Visual Analogue Scale (VAS)

Trial Locations

Locations (1)

Mohamed H Bakri; 🇪🇬 Assiut, Egypt